Compare YieldMax NVDA Option Income Strategy ETF (NVDY) vs Royalty Pharma plc Class A Ordinary Shares (RPRX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
YieldMax NVDA Option Income Strategy ETF vs Royalty Pharma plc Class A Ordinary Shares — how do they compare? YieldMax NVDA Option Income Strategy ETF trades at $12.62 (market cap $1.45B), while Royalty Pharma plc Class A Ordinary Shares trades at $56.52 (market cap $25.27B). The key difference: Royalty Pharma plc Class A Ordinary Shares is far larger — about 17.4× YieldMax NVDA Option Income Strategy ETF's market cap, and Royalty Pharma plc Class A Ordinary Shares pays a 1.66% dividend while YieldMax NVDA Option Income Strategy ETF pays none. Which is the better fit depends on your goals — on Pluang, investors hold YieldMax NVDA Option Income Strategy ETF for 43 Days and Royalty Pharma plc Class A Ordinary Shares for 0 Days on average.
| NVDY | RPRX | |
|---|---|---|
Market Cap | $1.45B | $25.27B |
Volume | 1,943,739 | 3,671,183 |
Sector | Income / Options Overlay | Health |
52-Week High | $17.21 | $63.96 |
52-Week Low | $11.58 | $35.44 |
Typical Hold Time | 43 Days | 0 Days |
Enterprise Value | — | $32.50B |
Dividend Yield | — | 1.66% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
NVDY, the YieldMax NVDA Option Income Strategy ETF, trades at $13.01, down slightly by 0.31% on the day. The technical outlook is bullish based on moving averages, though oscillators are neutral and RSI levels suggest overbought conditions. The fund generates weekly dividend distributions, with recent payouts ranging from $0.08 to $0.12, but faces criticism for potential net asset value erosion and capped upside participation relative to its underlying asset, NVIDIA stock.
The outlook for NVDY is mixed; it offers high distribution yields but structural limitations may hinder long-term capital appreciation. Investment opportunities include income generation in a low-volatility environment, while risks involve NAV erosion and reduced upside capture if NVIDIA's volatility declines. Analyst sentiment has shifted to hold ratings, reflecting concerns over sustainability.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About YieldMax NVDA Option Income Strategy ETF
NVDY is an actively managed ETF that pursues a synthetic covered call strategy on NVIDIA Corporation (NVDA) stock. The fund primarily sells call options on NVDA and invests in U.S. Treasury securities and other high-quality collateral. Its goal is to generate monthly income from the option premiums. This strategy provides exposure to the high-growth potential of NVDA while seeking to deliver a high yield, though it caps the potential capital appreciation of the stock.
Read more on NVDY →About Royalty Pharma plc Class A Ordinary Shares
Royalty Pharma acquires interests in royalties from biopharmaceutical products. Its model gives it exposure to medicines developed and sold by other life sciences companies.
Read more on RPRX →
